Heart disease kills 18 million people each year, but the development of new therapies faces a bottleneck: no physiological model of the entire human heart exists – so far. A new multi-chamber organoid ...

An advanced human heart organoid system can be used to model embryonic heart development under pregestational diabetes-like conditions, researchers report. The organoids recapitulate hallmarks of ...

Cardiovascular diseases (CVDs) remain the leading cause of death worldwide. Several risk factors, including genetics, sex, and age, increase the risk of CVDs. Other factors that contribute to CVD ...

Heart disease kills 18 million people each year, but the development of new therapies faces a bottleneck: no physiological model of the entire human heart exists – so far. A new multi-chamber organoid ...

An international team of researchers has discovered a natural mechanism that protects the heart from heart failure with preserved ejection fraction (HFpEF), a serious condition in need of effective ...

A study led by Maria Carmo-Fonseca at GIMM has helped clarify one of the main limitations of lab-grown heart cells, which are ...

Share on Pinterest Research shows that poor heart health may put people at risk of multiple musculoskeletal disorders. Ronald Martinez/Getty Images Researchers investigated the link between ...

The researchers say the technology could eventually support more personalised care, allowing treatments to be better matched ...

Tenaya Therapeutics (TNYA) is a very interesting biotech because it is in the process of developing two one-time gene therapies to treat patients with common genetic heart disorders. I believe that ...

Using a combination for spatial, single-cell transcriptomics and imaging data from 36 hearts, scientists from the KTH Royal Institute of Technology and their collaborators have come up with what they ...